Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.
Cell Transplant. 2010;19(6):831-9. doi: 10.3727/096368910X508951.
Definitive endoderm (DE) derived from stem cells holds potential to differentiate into hepatocytes. Stem cell therapy using those cells has potential for a treatment of liver disease. To date, various ways of inducing hepatocytes from embryonic stem (ES) cells have been reported by researchers. However, it has not been proved enough that induced pluripotent stem (iPS) cells behave in the same manner as ES cells in endoderm differentiation. The purpose of this study was to establish an efficient method to induce DE from iPS cells, through comparatively analyzing the efficacy of endoderm formation from mouse ES cells. Furthermore, the efficiency of a serum-free medium in the differentiation into DE was investigated. Mouse ES cells and iPS cells were floated in culture medium for 2 or 5 days and embryoid bodies (EB) were formed. Subsequently, DE was induced with 100 ng/ml activin A and 100 ng/ml basic fibroblast growth factor (bFGF). RT-PCR and real-time PCR analyses were carried out at each step to determine the gene expression of EB markers. The difference in cellular proliferation between serum-containing and serum-free media was examined by an MTS assay in EB and DE induction. iPS cells showed the paralleled mRNA expression to ES cells in each step of differentiation into EB, but the levels of expression of Sox17 and Foxa2 were relatively higher in ES cell-derived DE, whereas Cxcr4 expression was higher in iPS cell-derived DE. The utilization of serum-free medium for iPS cells showed significantly favorable cellular proliferation during EB formation and subsequent DE induction. Forming EB for 5 days and subsequently DE induction with activin A and bFGF with serum-free medium was an appropriate protocol in iPS cells. This may represent an important step for generating hepatocytes from iPS cells for the development of cell therapy.
终末内胚层(DE)来源于干细胞,具有分化为肝细胞的潜力。使用这些细胞的干细胞治疗具有治疗肝病的潜力。迄今为止,研究人员已经报道了各种从胚胎干细胞(ES)诱导肝细胞的方法。然而,尚未充分证明诱导多能干细胞(iPS)在向内胚层分化时的行为与 ES 细胞相同。本研究的目的是通过比较分析从小鼠 ES 细胞中形成内胚层的效果,建立一种从 iPS 细胞中诱导 DE 的有效方法。此外,还研究了无血清培养基在 DE 分化中的效率。将小鼠 ES 细胞和 iPS 细胞在培养基中漂浮 2 或 5 天形成类胚体(EB)。随后,用 100ng/ml 的激活素 A 和 100ng/ml 的碱性成纤维细胞生长因子(bFGF)诱导 DE。在每个步骤中进行 RT-PCR 和实时 PCR 分析,以确定 EB 标记物的基因表达。通过 MTS 测定法在 EB 和 DE 诱导中检查含血清和无血清培养基之间细胞增殖的差异。iPS 细胞在分化为 EB 的每个步骤中均显示出与 ES 细胞平行的 mRNA 表达,但 Sox17 和 Foxa2 的表达水平在 ES 细胞衍生的 DE 中相对较高,而 Cxcr4 的表达在 iPS 细胞衍生的 DE 中较高。无血清培养基的使用在 EB 形成和随后的 DE 诱导过程中对 iPS 细胞的细胞增殖显示出明显的有利影响。使用无血清培养基形成 5 天的 EB,随后用激活素 A 和 bFGF 诱导无血清培养基中的 DE,这是 iPS 细胞的合适方案。这可能是从 iPS 细胞生成用于细胞治疗的肝细胞的重要步骤。